Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 4, 2001, Pages 336-343

  Blanch, Jordi ^a   Martínez, Esteban ^a   Rousaud, Araceli ^a   Blanco, José Luís ^a   García Viejo, Miguel Ángel ^a   Peri, Josep Maria ^a   Mallolas, Josep ^a   De Lazzari, Elisa ^a   De Pablo, Joan ^a   Gatell, Josep Maria ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Efavirenz; Neuropsychiatric; Prospective; Quality of life

Indexed keywords

EFAVIRENZ;

ACADEMIC ACHIEVEMENT; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DISTRESS SYNDROME; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; PRIORITY JOURNAL; PSYCHOPATHY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SOMATIZATION;

EID: 0035423911     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200108010-00003     Document Type: Article

References (30)

1. Efavirenz
2. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: An overview of cases in Japan
3. Manic episodes in two patients treated with interferon alpha
4. Manic syndrome associated with zidovudine treatment
5. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection
6. Evidence for reliability, validity and usefulness of the Medical Outcomes Study Health Survey (MOS-HIV)
7. Evaluating changes in health status in HIV-infected patients; MOS-HIV and MQOL. HIV quality of life questionnaires
8. The effects of daily stressors and life events on mental health in a cohort of gay men at risk for AIDS
9. Heterosexuals and HIV disease: Controlled study of psychological factors associated with psychiatric distress _rfsti VIII International Conference on AIDS
10. Quality of life assessment comes of age in the era of highly active antiretroviral therapy
11. Potential factors affecting adherence with HIV therapy
12. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection
13. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection
14. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection
15. Depressive symptoms decline among persons on HIV protease inhibitors
16. Fat distribution and metabolic changes in patients with HIV infection
17. Use of efavirenz in a low income population
18. Psychiatric safety of efavirenz
19. WHO Neuropsychiatric AIDS Study, cross-sectional phase I
20. Prevalence of axis I disorders in an AIDS cohort: A cross-sectional, controlled study
21. Human immunodeficiency virus (HIV) infection and quality of life: The potential impact of axis I psychiatric disorders in a sample of 95 HIV seropositive men
22. The relationship of alexithymia to subjective and biomedical measures of disease
23. The amplification of somatic symptoms